Nelly Frossard
Nelly Frossard
Research Director at Inserm (french NIH)
Verified email at - Homepage
Cited by
Cited by
Stem cell factor and its receptor c-Kit as targets for inflammatory diseases
L Reber, CA Da Silva, N Frossard
European journal of pharmacology 533 (1-3), 327-340, 2006
Neurogenic mechanisms in bronchial inflammatory diseases
DA Groneberg, D Quarcoo, N Frossard, A Fischer
Allergy 59 (11), 1139-1152, 2004
The nerve growth factor and its receptors in airway inflammatory diseases
V Freund-Michel, N Frossard
Pharmacology & therapeutics 117 (1), 52-76, 2008
Transforming growth factor-β and its role in asthma
C Duvernelle, V Freund, N Frossard
Pulmonary pharmacology & therapeutics 16 (4), 181-196, 2003
Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma
Z Zhang, P Hener, N Frossard, S Kato, D Metzger, M Li, P Chambon
Proceedings of the National Academy of Sciences 106 (5), 1536-1541, 2009
Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation
L Reber, L Vermeulen, G Haegeman, N Frossard
PloS one 4 (2), e4393, 2009
Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase.
N Frossard, KJ Rhoden, PJ Barnes
Journal of Pharmacology and Experimental Therapeutics 248 (1), 292-298, 1989
Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.
Y Amrani, RA Panettieri Jr, N Frossard, C Bronner
American journal of respiratory cell and molecular biology 15 (1), 55-63, 1996
Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low‐dose
O Kassel, F De Blay, C Duvernelle, C Olgart, D Israel‐Biet, P Krieger, ...
Clinical & Experimental Allergy 31 (9), 1432-1440, 2001
Nerve growth factor and its receptors in asthma and inflammation
N Frossard, V Freund, C Advenier
European journal of pharmacology 500 (1-3), 453-465, 2004
Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
J Becker, C Delayre‐Orthez, N Frossard, F Pons
Fundamental & clinical pharmacology 20 (5), 429-447, 2006
Nerve growth factor levels and localisation in human asthmatic bronchi
CO Höglund, F De Blay, JP Oster, C Duvernelle, O Kassel, G Pauli, ...
European Respiratory Journal 20 (5), 1110-1116, 2002
New insights into the second generation antihistamines
GM Walsh, L Annunziato, N Frossard, K Knol, S Levander, JM Nicolas, ...
Drugs 61, 207-236, 2001
Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids
C Olgart, N Frossard
European Respiratory Journal 18 (1), 115-121, 2001
Small neutralizing molecules to inhibit actions of the chemokine CXCL12
M Hachet-Haas, K Balabanian, F Rohmer, F Pons, C Franchet, S Lecat, ...
Journal of Biological Chemistry 283 (34), 23189-23199, 2008
Arachidonic acid metabolites and airway epithelium-dependent relaxant factor.
E Tschirhart, N Frossard, C Bertrand, Y Landry
Journal of Pharmacology and Experimental Therapeutics 243 (1), 310-316, 1987
PPARα downregulates airway inflammation induced by lipopolysaccharide in the mouse
C Delayre-Orthez, J Becker, I Guenon, V Lagente, J Auwerx, N Frossard, ...
Respiratory research 6, 1-10, 2005
Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions
V Freund, F Pons, V Joly, E Mathieu, N Martinet, N Frossard
European Respiratory Journal 20 (2), 458-463, 2002
Clinical and Inflammatory Responses to Exogenous Tachykinins in Allergic Rhinitis1-3
G Braunstein, I Fajac, J Lacronique, N Frossard
Am Rev Respir Dis 144, 630-635, 1991
Tachykinin receptors and the airways
N Frossard, C Advenier
Life sciences 49 (26), 1941-1953, 1991
The system can't perform the operation now. Try again later.
Articles 1–20